iBio

(NASDAQ) IBIO

Current Price$1.68

Market Cap$83.96M

Since IPO (2008)-100%

5 Year-100%

1 Year+88%

1 Month+13%

iBio Financials at a Glance

Market Cap

$83.96M

Revenue (TTM)

$300.00K

Net Income (TTM)

-$27.61M

EPS (TTM)

-$0.58

P/E Ratio

-2.93

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$1.68

Volume

912,081

Open

$1.61

Price

$1.68

Volume

912,081

Open

$1.61

Previous Close

$1.69

Daily Range

$1.61 - $1.73

52-Week Range

$0.56 - $3.82

Estimated Earnings Date

Sep 4, 2026

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$1.68

Volume

912,081

Open

$1.61

Previous Close

$1.69

Daily Range

$1.61 - $1.73

52-Week Range

$0.56 - $3.82

Estimated Earnings Date

Sep 4, 2026

IBIO News

Is It Too Late to Buy iBio Stock?

Zhiyuan SunOct 29, 2020

3 Popular Robinhood Stocks That Could Realistically Double Within 1 Year

Keith SpeightsOct 8, 2020

3 Compelling Biotech Stocks to Consider Buying While They're Hot on Robinhood

Alex CarchidiSep 20, 2020

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About iBio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Martin B. Brenner, PhD, DVM

Website

www.ibioinc.com

Headquarters

Bryan, TX 77807, US

IBIO Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-80%

Net Income Margin

-92%

Return on Equity

-62%

Return on Capital

-30%

Return on Assets

-32%

Earnings Yield

-34.13%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$83.96M

Shares Outstanding

49.68M

Volume

912.08K

Avg. Volume

946.57K

Financials (TTM)

Gross Profit

$400.00K

Operating Income

-$18.60M

EBITDA

-$17.04M

Operating Cash Flow

-$15.30M

Capital Expenditure

-$16.00K

Free Cash Flow

-$15.32M

Cash & ST Invst.

$8.58M

Total Debt

$3.51M

iBio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$250.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$83.96M

N/A

Market Cap/Employee

$5.25M

N/A

Employees

N/A

Net Income

-$7.73M

-59.0%

EBITDA

-$7.46M

-64.8%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

$74.80M

+1408.3%

Total Debt

$2.33M

-38.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.79M

-22.9%

Short Term Debt

$532.00K

-62.8%

Return on Assets

-32.16%

N/A

Return on Invested Capital

-30.20%

N/A

Free Cash Flow

-$6.10M

-95.4%

Operating Cash Flow

-$6.08M

-95.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RLYBRallybio Corporation

RLYBRallybio Corporation$15.97+0.31%

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.43+2.14%

ANTXAN2 Therapeutics, Inc.

ANTXAN2 Therapeutics, Inc.$5.00+2.04%

KLTOKlotho Neurosciences, Inc.

KLTOKlotho Neurosciences, Inc.$0.38-7.10%

PLURPluri Inc.

PLURPluri Inc.$2.02-10.22%

XCURExicure, Inc.

XCURExicure, Inc.$2.31+7.44%

PSTVPlus Therapeutics, Inc.

PSTVPlus Therapeutics, Inc.$4.20-2.55%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.49-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.99+0.04%

TAT&T

TAT&T$22.01-0.02%

AAPLApple

AAPLApple$298.01+0.01%

CMCSAComcast

CMCSAComcast$22.43-0.01%

BACBank of America

BACBank of America$56.20-0.01%

RKLBRocket Lab

RKLBRocket Lab$107.24-0.01%

Questions About IBIO

What is the current price of iBio?

iBio is trading at $1.69 per share.

What is the 52-week range for iBio?

Over the past 52 weeks, iBio has traded between $0.56 and $3.82.

How much debt does iBio have?

As of the most recent reporting period, iBio reported total debt of $2.33M.

How much cash does iBio have on hand?

iBio reported $47.63M in cash and cash equivalents in its most recent financial results.

What is iBio’s dividend yield?

iBio does not currently have a dividend yield.

iBio

iBio Financials at a Glance

IBIO News

This Under-the-Radar Pharma Company Could Be a Bargain Hunter's Dream

Here's Why iBio Stock Surged Friday

Why iBio Stock Soared Today

Why iBio Stock Soared Today

These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020

Is It Too Late to Buy iBio Stock?

3 Popular Robinhood Stocks That Could Realistically Double Within 1 Year

3 Compelling Biotech Stocks to Consider Buying While They're Hot on Robinhood

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About iBio

IBIO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

iBio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IBIO

What is the current price of iBio?

What is the 52-week range for iBio?

How much debt does iBio have?

How much cash does iBio have on hand?

What is iBio’s dividend yield?

Premium Investing Services